PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
PBRM1, encoding for a subunit of the SWI/SNF complex, is the second most frequently mutated gene in clear cell renal cell carcinoma (ccRCC). Here, the authors show that PBRM1 loss reduces IFNγ-mediated signalling resulting in a less immunogenic tumor microenvironment and that PBRM1 mutations correla...
Guardado en:
Autores principales: | Xian-De Liu, Wen Kong, Christine B. Peterson, Daniel J. McGrail, Anh Hoang, Xuesong Zhang, Truong Lam, Patrick G. Pilie, Haifeng Zhu, Kathryn E. Beckermann, Scott M. Haake, Sevinj Isgandrova, Margarita Martinez-Moczygemba, Nidhi Sahni, Nizar M. Tannir, Shiaw-Yih Lin, W. Kimryn Rathmell, Eric Jonasch |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c2ffa7605cd4f008c5d3c780840e07f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
por: Daniel J. McGrail, et al.
Publicado: (2018) -
PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth
por: Weijia Cai, et al.
Publicado: (2019) -
Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis
por: Judit Espana-Agusti, et al.
Publicado: (2017) -
HIF1α and HIF2α exert distinct nutrient preferences in renal cells.
por: Alexandra Arreola, et al.
Publicado: (2014) -
Barriers to getting into postgraduate specialty training for junior Australian doctors: An interview-based study.
por: Belinda O'Sullivan, et al.
Publicado: (2021)